Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma.

Created on 02 Jul 2026

Authors

Joseph G Schroers-Martin, Reid Merryman, Michael A Spinner, Austin Yeung, Cheryl Chang, Chandley Silin, May Powell, Philippe Armand, Margaret Shipp, Ranjana Advani

Published in

Haematologica. Jul 02, 2026. Epub Jul 02, 2026.

Abstract

Not available.

PMID:
42389806
Bibliographic data and abstract were imported from PubMed on 02 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement